Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + steroids versus low-dose CNI + MMF + steroids after renal transplantation
2009-014436-38Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of everolimus, cyclosporine, tacrolimus, mycophenolate mofetil and prednisolone in Kidney allograft status (RTx) and kidney transplant immunosuppression (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Renal function. Started Jul 2009; status: active.
02
Drugs
everolimuscyclosporinetacrolimusmycophenolate mofetilprednisolone
03
Conditions
Kidney allograft status (RTx)kidney transplant immunosuppression
Beyond the preview
Go deeper on 2009-014436-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014436-38.